Back to search

Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy

Data up to Jan 2025

Published2001
Citations27
References49

Total Citations Per Year

Abstract

References (49)

SF-36 health survey: Manual and interpretation guide

2003 • 11,679 citations

Natural History of Progression After PSA Elevation Following Radical Prostatectomy

1999 • 2,993 citations

The rand 36‐item health survey 1.0

1993 • 2,597 citations

Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate Cancer

1999 • 1,224 citations

Quality-of-Life Outcomes in Men Treated for Localized Prostate Cancer

1995 • 1,034 citations

SF-36 Health Survey.

2008 • 969 citations

Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial

1997 • 666 citations

Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases

1994 • 416 citations

Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen

1993 • 380 citations

BICALUTAMIDE MONOTHERAPY COMPARED WITH CASTRATION IN PATIENTS WITH NONMETASTATIC LOCALLY ADVANCED PROSTATE CANCER: 6.3 YEARS OF FOLLOWUP

2000 • 349 citations

Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma.

1990 • 314 citations

A Randomised Comparison of ‘Casodex’<sup>TM</sup> (Bicalutamide) 150 mg Monotherapy versus Castration in the Treatment of Metastatic and Locally Advanced Prostate Cancer

1998 • 310 citations

Hormone Therapy for Prostate Cancer: Results of the Veterans Administration Cooperative Urological Research Group Studies

1989 • 304 citations

Intermittent androgen suppression in the treatment of prostate cancer: A preliminary report

1995 • 296 citations

Quality-of-life outcomes in men treated for localized prostate cancer

1995 • 281 citations

Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues

1986 • 252 citations

Finasteride

1994 • 229 citations

Local recurrence after radical prostatectomy: Characteristics in size, location, and relationship to prostate-specific antigen and surgical margins

1996 • 216 citations

Intermittent endocrine therapy for advanced prostate cancer

1986 • 212 citations

Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model

1996 • 192 citations

Bicalutamide Monotherapy Versus Flutamide Plus Goserelin in Prostate Cancer Patients: Results of an Italian Prostate Cancer Project Study

1999 • 157 citations

Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: A pilot study

1996 • 147 citations

Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Investigate the Effect of Finasteride (MK-906) on Stage D Prostate Cancer

1992 • 124 citations

Radiotherapy after radical prostatectomy: treatment outcomes and failure patterns

1999 • 122 citations

Treatment with finasteride following radical prostatectomy for prostate cancer

1995 • 121 citations

USE OF SECOND TREATMENT FOLLOWING DEFINITIVE LOCAL THERAPY FOR PROSTATE CANCER: DATA FROM THE caPSURE DATABASE

1998 • 120 citations

Intermittent androgen suppression in the management of prostate cancer

1999 • 119 citations

Hormonal control of growth and progression in tumors of Nb rats and a theory of action.

1977 • 112 citations

A controlled trial of bicalutamide versus castration in patients with advanced prostate cancer

1996 • 91 citations

Intermittent Androgen Suppression for Prostate Cancer: Rationale and Clinical Experience

1998 • 91 citations

Combination Finasteride and Flutamide in Advanced Carcinoma of the Prostate: Effective Therapy with Minimal Side Effects

1995 • 89 citations

Single-agent therapy with bicalutamide: A comparison with medical or surgical castration in the treatment of advanced prostate carcinoma

1995 • 85 citations

Combined finasteride and flutamide therapy in men with advanced prostate cancer

1996 • 84 citations

Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate

1997 • 84 citations

Intermittent Androgen Deprivation for Clinically Localized Prostate Cancer: Initial Experience

1998 • 72 citations

Intermittent androgen deprivation after PSA-complete response as a strategy to reduce induction of hormone-resistant prostate cancer

1997 • 69 citations

Intermittent Complete Androgen Blockade in PSA Relapse after Radical Prostatectomy and Incidental Prostate Cancer

1999 • 67 citations

MANAGEMENT OF A POSITIVE SURGICAL MARGIN AFTER RADICAL PROSTATECTOMY: DECISION ANALYSIS

2000 • 59 citations

A pilot study of intermittent androgen deprivation in advanced prostate cancer

1998 • 54 citations

Loss of androgen dependence is associated with an increase in tumorigenic stem cells and resistance to cell-death genes

1990 • 44 citations

Intermittent Endocrine Therapy of Prostate Cancer

1996 • 40 citations

Current status of intermittent androgen suppression in the treatment of prostate cancer

1998 • 39 citations

Long-Term Combined Androgen Blockade Alone for Localized Prostate Cancer.

1999 • 36 citations

Paracrine growth stimulation of androgen-responsive Shionogi Carcinoma 115 by its autonomous subline (Chiba Subline 2).

1990 • 28 citations

Clinical profile of a new non-steroidal antiandrogen

1990 • 26 citations

Early Results of LH-RH Agonist Treatment with or without Chlormadinone Acetate for Hormone Therapy of Naive Localized or Locally Advanced Prostate Cancer: A Prospective and Randomized Study

2000 • 21 citations

ANDROGEN DEPRIVATION THERAPY USING FINASTERIDE AND LOW DOSE FLUTAMIDE TO TREAT PSA FAILURE FOLLOWING THERAPY FOR CLINICALLY LOCALIZED ADENOCARCINOMA OF THE PROSTATE (CaP)

1999 • 17 citations

Long‐Term Follow‐Up of Patients Treated with Intermittent Hormone Therapy for Advanced Prostate Cancer

1999 • 2 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database

Androgen deprivation therapy for patients with clinically localized (stages T1 to T3)… (2001) – Urology | Metascience Observatory Explorer